New records and invasion risk of Stenochrus portoricensis Chamberlin, 1922 (Schizomida: Hubbardiidae) in Brazil

Posted by
  New records and invasion risk of Stenochrus portoricensis Chamberlin, 1922 (Schizomida: Hubbardiidae) in Brazil Abstract Stenochrus portoricensis Chamberlin, 1922 is a schizomid native to the Caribbean and Central America and is notable for facultative parthenogenesis and a broad synanthropic distribution. It is widely reported as an exotic species in several regions worldwide, with recognized invasive potential. Here, we expand its known distribution in Brazil by documenting the first records from the state of Mato Grosso and new occurrences in tourist caves in Bahia. We also model the species’ potential distribution in South America using the Maximum Entropy (MaxEnt) algorithm under current and future climate scenarios. The models indicate higher habitat suitability in regions characterized by low annual temperature variation and consistent rainfall patterns, conditions typical of tropical and subterranean environments, and predict range expansion under future climate change, p...

The recombinant protein of scorpion venom phospholipase A2 exhibits potential anti-leishmanial activity

Posted by

 

By Guy Haimovitch - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=630282

The recombinant protein of scorpion venom phospholipase A2 exhibits potential anti-leishmanial activity

Abstract

The venom of scorpions contains a diverse array of bioactive compounds, including mucoproteins, nucleotides, and enzymes. Among these, phospholipase A2 (PLA2) plays a critical role in hydrolyzing plasma membrane phospholipids, leading to the release of fatty acids and lysophospholipids. In this study, characterized Maurolipin was selected as a candidate for recombinant protein production and evaluation of its anti-leishmanial activity. The recombinant protein was expressed in Escherichia coli strain Origami (DE3) and purified using a Ni-NTA resin column. The anti-parasitic activity of Maurolipin was tested against Leishmania major promastigotes, the causative agent of zoonotic cutaneous leishmaniasis (ZCL). The growth inhibitory effect was assessed across a range of concentrations (40 to 0.07 μg/ml). Leishmanicidal activity was determined by propidium iodide (PI) staining and flow cytometry, while cytotoxicity to RAW 264.7 macrophages was evaluated using an MTT assay. Maurolipin exhibited potent anti-leishmanial effects, with a 24-hour growth inhibition IC50 of 6.5 μg/ml and a leishmanicidal LC50 of 9.06 μg/ml after 3 hours of exposure. Cytotoxic effects on macrophages were dose- and time-dependent. These findings suggest that recombinant Maurolipin possesses growth-inhibitory and apoptosis-inducing properties, highlighting its potential as a novel therapeutic agent for leishmaniasis.

Soltan-Alinejad, P., Ramezani, A., Asgari, Q. et al. The recombinant protein of scorpion venom phospholipase A2 exhibits potential anti-leishmanial activity. Sci Rep (2025). https://doi.org/10.1038/s41598-025-29796-4